Titan Biotech's Asset Turnover Ratio tells a powerful story: from 1.18x in FY2015 to a peak of 1.42x during COVID demand to 0.94x during the current capex phase. A deep-dive case study.
MGMANISH GOEL PMS☰ HomePast PerformanceServicesMedia & PressBlogsAwards WhatsApp · 7380122211 VALUE INVESTING · BLOG Interest Coverage Ratio: The Debt Safety Metric That Reveals Whether a Company […]
MGMANISH GOEL PMS☰ HomePast PerformanceServicesMedia & PressBlogsAwards WhatsApp · 7380122211 VALUE INVESTING · BLOG Zero Promoter Pledging ← ALL ARTICLES In the Indian stock market, there […]
MGMANISH GOEL PMS☰ HomePast PerformanceServicesMedia & PressBlogsAwards WhatsApp · 7380122211 VALUE INVESTING · BLOG Cash & Investments Growth ← ALL ARTICLES In the world of fundamental […]